Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Early pregnancy blood pressure patterns tied to hypertension risk years later
Researchers show certain blood pressure patterns during the first 20 weeks of pregnancy were more likely to develop into hypertension later in life.
Heart Rhythm Society legislative advocacy group raising funds for electrophysiology
This week, Heart Rhythm Advocates announced its establishment and called on cardiologists and EPs to support its efforts with membership and joining committees to guide efforts.
Key takeaways from ACC.25: Advances in cardiovascular science
Former American College of Cardiology president Hadley Wilson, MD, executive vice chair of Atrium Health Sanger Heart and Vascular Institute, explains his main takeaway messages from the ACC 2025 late-breaking trials.
New TAVR research explores adverse outcomes, disease progression in patients with asymptomatic severe AS
Two separate studies at ACC.25 explored data from the EARLY TAVR trial. One analysis included stroke findings that surprised researchers.
Dapagliflozin improves outcomes for elderly TAVR patients with heart failure
The positive data were presented as part of a late-breaking clinical trial at ACC.25 in Chicago. One cardiologist on stage for the presentation said these findings will impact the way he manages certain TAVR patients.

TAVR-related stroke, the authors wrote, is a "critically important and potentially preventable source of patient morbidity."

'Highly significant' MRI findings link hyperthyroidism to structural brain abnormalities

“For decades, the patients in our group have testified that they don’t feel they’ve recovered, and we hope our study will provide further clues about what happens in the brain,” experts involved in the study said.

Long-term risk of heart attack, coronary artery disease or stroke much higher among COVID-19 patients

Even patients who were never hospitalized for COVID-19 face a heightened risk of cardiovascular issues.

An example of the CV Wizard clinical decision support (CDS) software showing a screen designed to help patients better understand their risks and areas they need to work on. It is graphically based to enable patients who have a lower level of literacy better understand their cardiovascular risks, rather than using a long text report.

Clinical decision support may improve cardiac care at low-income community health centers

Evidence shows this technology has the potential to improve care for vulnerable patients with cardiovascular disease.

Mammograms should not be delayed after COVID vaccine, research shows

Reactive axillary lymph nodes seen on screening mammograms after vaccination can last for many months and should not be cause for imaging delays, experts reported in Radiology.

IVUS guidance during DES implantation boosts long-term outcomes

Researchers focused on data from two previous trials to track the impact of IVUS guidance on mortality rates and other key outcomes after three years.

The Abbott Aveir DR dual-chamber leadless pacemaker recently had its first human implant occur in the Aveir DR i2i study pivotal trial.

First implant of dual-chamber leadless pacemaker completed in Abbott’s Aveir DR i2i pivotal trial

The investigational dual-chamber pacemaker is designed to provide synchronous, beat-by-beat pacing of the right atrium and right ventricle of the heart.

AHIP urges Congress to curtail price gouging on COVID-19 tests: ‘The problem has gotten worse’

In some cases, out-of-network providers charged $185 for a test that costs $130, on average, America’s Health Insurance Plans stated in a recent letter.

Clinical

Early pregnancy blood pressure patterns tied to hypertension risk years later

Heart Rhythm Society legislative advocacy group raising funds for electrophysiology

Key takeaways from ACC.25: Advances in cardiovascular science

New TAVR research explores adverse outcomes, disease progression in patients with asymptomatic severe AS

Dapagliflozin improves outcomes for elderly TAVR patients with heart failure